Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.318 USD | +5.73% | +6.36% | -14.91% |
Apr. 01 | Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating | MT |
Apr. 01 | HC Wainwright Adjusts Affimed's Price Target to $10 From $50, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.91% | 76.59M | |
-2.62% | 103B | |
+1.53% | 95.28B | |
+1.46% | 22.15B | |
-15.72% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.94% | 16.05B | |
+5.14% | 13.68B | |
+33.73% | 12.17B |
- Stock Market
- Equities
- AFMD Stock
- News Affimed N.V.
- Affimed to Sell AbCheck to Ampersand Biomedicines for $6 Million in Cash, Stock; Shares Fall